Cholera control in endemic regions of Africa: assessing mass preventative OCV campaigns impacts and strategies
In plain English
AI plain-English summaryCholera vaccines are being given to entire populations in two cities in the Democratic Republic of Congo to find out how well they work and how often people need them. Cholera kills thousands of people each year in Africa, and the oral cholera vaccine (OCV) is recommended for prevention, but no one knows the best way to use it—how long protection lasts, whether children need different doses, or how population movement affects coverage. This project fills those gaps by tracking confirmed cases in Goma and Bukama, using a case-cohort design to calculate vaccine effectiveness by age and regimen, and running regular surveys on coverage, migration, and access to care. If the research succeeds, health authorities in cholera-endemic regions will have clear, evidence-based guidelines on revaccination timing and campaign design. That could shift cholera control from reactive outbreak response to sustained, cost-effective prevention—saving lives and reducing strain on fragile health systems without requiring dramatic new infrastructure. The collaboration with DRC authorities and Epicentre’s long-standing field presence means the results are likely to be implemented quickly where they matter most.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Directed CallPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know